Published in Antimicrob Agents Chemother on January 01, 1981
Comparative activities of 13 beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 4.13
Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans. Antimicrob Agents Chemother (1983) 3.46
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
Multiple-dose pharmacokinetics of imipenem-cilastatin. Antimicrob Agents Chemother (1984) 1.98
Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics. Antimicrob Agents Chemother (1982) 1.46
A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives. Antimicrob Agents Chemother (1982) 1.30
Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci. Antimicrob Agents Chemother (1983) 1.16
In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin. Antimicrob Agents Chemother (1982) 1.05
Synergism between N-formimidoyl thienamycin and gentamicin or tobramycin against enterococci. Antimicrob Agents Chemother (1982) 0.97
Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1981) 0.93
Imipenem therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother (1986) 0.92
Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Antimicrob Agents Chemother (1986) 0.87
Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis. Antimicrob Agents Chemother (1985) 0.86
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother (1984) 0.83
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 0.81
Synergistic effect of N-formimidoyl thienamycin with gentamicin and amikacin against Streptococcus faecalis. Antimicrob Agents Chemother (1983) 0.80
Effect of imipenem-cilastatin therapy on fecal flora. Antimicrob Agents Chemother (1986) 0.77
[Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery]. Infection (1986) 0.75
MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities. Antimicrob Agents Chemother (1980) 9.02
In vitro activity of thienamycin. Antimicrob Agents Chemother (1978) 8.76
Thienamycin: new beta-lactam antibiotic with potent broad-spectrum activity. Antimicrob Agents Chemother (1979) 5.81
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrob Agents Chemother (1980) 5.47
In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1979) 1.87
Performance of four computer-based diagnostic systems. N Engl J Med (1994) 9.40
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Studies on the bacteremia of bacterial endocarditis. JAMA (1967) 5.00
The impact of chronic pain in the community. Fam Pract (2001) 2.58
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS (1998) 2.35
Rural and urban differences in stage at diagnosis of colorectal and lung cancers. Br J Cancer (2001) 2.12
Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer (2000) 1.97
In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1979) 1.87
IUD and endocarditis. Ann Intern Med (1973) 1.85
Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial. Clin Infect Dis (2010) 1.69
Prosthetic valve endocarditis. Circulation (1984) 1.60
Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer (2002) 1.55
Group C streptococcal pneumonia: report of a fatal case and review of the literature. Rev Infect Dis (1981) 1.48
Subdural empyema: analysis of 32 cases and review. Clin Infect Dis (1995) 1.45
Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. Int J Tuberc Lung Dis (2001) 1.44
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Conjugation in Tetrahymena. Science (1952) 1.39
Antibacterial mechanisms in the urinary bladder. Yale J Biol Med (1967) 1.38
Chronic pain and the use of conventional and alternative therapy. Fam Pract (2003) 1.37
Clinical evaluation of moxalactam. Antimicrob Agents Chemother (1981) 1.33
Diphtheroid endocarditis after insertion of a prosthetic heart valve. Report of two cases. JAMA (1968) 1.30
Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunol (2006) 1.21
Biochemical and ultrastructural changes in Tetrahymena pyriformis during starvation. J Protozool (1968) 1.21
Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. Sex Transm Infect (2006) 1.15
An ultrastructural study of ingestion and digestion in Tetrahymena pyriformis. J Protozool (1966) 1.14
Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev Infect Dis (1982) 1.12
Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. Clin Exp Immunol (1993) 1.12
Effects of a decision support system on physicians' diagnostic performance. J Am Med Inform Assoc (1999) 1.10
Persistent bacteremia in staphylococcal endocarditis. Am J Med (1978) 1.07
Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study. Trans R Soc Trop Med Hyg (1995) 1.04
Q fever endocarditis. Am J Med Sci (1986) 1.02
Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus spp. Bronchopulmonary infections. Antimicrob Agents Chemother (1979) 1.00
Infections in cardiac pacemakers. Curr Clin Top Infect Dis (1988) 0.98
Possible new variant of Nijmegen breakage syndrome. Am J Med Genet (1996) 0.97
Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries. Thorax (1994) 0.96
Comparison of cilofungin and amphotericin B for therapy of murine candidiasis. Antimicrob Agents Chemother (1990) 0.96
Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary disease. Antimicrob Agents Chemother (1979) 0.95
Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Lung (1997) 0.94
Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother (1980) 0.94
Modification of bacterial serum susceptibility by rifampin. Infect Immun (1980) 0.93
Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications. Ann Surg (1974) 0.92
Adaptation of Western measures of cognition for assessing 5-year-old semi-urban Ugandan children. Br J Educ Psychol (2009) 0.90
Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection. Antimicrob Agents Chemother (1973) 0.89
Ceftriaxone: in vitro studies and clinical evaluation. Antimicrob Agents Chemother (1982) 0.89
Persistent gram-negative bacteremia. Observations in twenty patients. Am J Surg (1973) 0.89
Deletion of 22q11 in two brothers with different phenotype. Am J Med Genet (1998) 0.89
Elevated serum D-arabinitol levels in patients with sarcoidosis. J Clin Microbiol (1984) 0.89
Molecular bases for inherited human complement component C6 deficiency in two unrelated individuals. J Immunol (1996) 0.89
Cardiac, cerebral, and vascular complications of infective endocarditis. Cardiol Clin (1996) 0.88
Pseudallescheria boydii infection of the central nervous system in a cardiac transplant recipient. South Med J (1986) 0.87
Indications for cardiac surgery in patients with active infective endocarditis. Am J Med (1985) 0.87
HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis. AIDS (2001) 0.87
Fluorescence labeling of bacteria for studies of intracellular pathogenesis. J Immunol Methods (1995) 0.86
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis (1992) 0.86
The value of wide-needle aspiration in the diagnosis of tuberculous lymphadenitis in Africa. AIDS (1993) 0.85
Inverse association between BCG immunisation and intestinal nematode infestation among HIV-1-positive individuals in Uganda. Lancet (1999) 0.85
Respiratory infections. Med Times (1981) 0.83
Cigarette smoke: the effect of residue on mitochondrial structure. Science (1970) 0.83
Prosthetic valve endocarditis caused by Histoplasma capsulatum. JAMA (1979) 0.83
Infection complicating renal homotransplantation: a prospective study. Ala J Med Sci (1971) 0.82
A golgi apparatus associated with mating in Tetrahymena pyriformis. J Cell Biol (1968) 0.80
Severe intrauterine growth retardation with increased mitomycin C sensitivity, or Nijmegen breakage syndrome? J Med Genet (1995) 0.80
The Level of Expressed Need--a measure of help-seeking behaviour for chronic pain in the community. Eur J Pain (2001) 0.80
The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'. Trop Med Int Health (2014) 0.79
The effect of tuberculin skin testing on viral load and anti-mycobacterial immune responses in HIV-1-infected Ugandan adults. Int J Tuberc Lung Dis (2004) 0.79
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 0.78
Failure of colchicine in the treatment of Mollaret's meningitis. Arch Intern Med (1984) 0.78
An ultrastructural study of the effects of aeration and physical activity on aging in Tetrahymena pyriformis. J Exp Zool (1966) 0.78
Effects of hyperthermia on Tetrahymena. I. Localization of acid hydrolases and changes in cell ultrastructure. Exp Cell Res (1969) 0.78
Bacteriostatic versus bactericidal activity. Infect Dis Clin North Am (1989) 0.77
Recurrent tetanus. South Med J (1971) 0.77
Endocarditis at the millennium. J Infect Dis (1999) 0.77
Serratia endocarditis in patients with a Starr-Edwards valve: report of a case of bacteriologic cure with antimicrobial therapy. South Med J (1973) 0.77
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species. Eur J Clin Microbiol Infect Dis (1991) 0.77
Correlation between the temperature dependence of intrinsic MR parameters and thermal dose measured by a rapid chemical shift imaging technique. NMR Biomed (2011) 0.76
Progress in management of patients with infective endocarditis. Trans Am Clin Climatol Assoc (1982) 0.75
Treatment of tuberculosis in developing countries. Lancet (1995) 0.75
Fate of surgical registrars in the South-Western Region. Br Med J (1970) 0.75
Treatment of tuberculosis in HIV-infected patients in Zaire. N Engl J Med (1995) 0.75
Interaction of cefotaxime and aminoglycosides against enterococci in vitro. Antimicrob Agents Chemother (1983) 0.75
Tuberculosis and immunodeficiency in HIV-1-infected patients in Africa. Lancet (1993) 0.75
The newer cephalosporins. Aztreonam and imipenem. Infect Dis Clin North Am (1995) 0.75
Clinical approach to infective endocarditis. Cardiol Clin (1996) 0.75
Production of low budget television programs in Alberta. Can J Public Health (1968) 0.75
Campylobacter pylori. Infectious cause of ulcers. Ala J Med Sci (1988) 0.75
Effect of coolant flow on the performance of round sapphire tips in a saline field. Lasers Surg Med (1992) 0.75
Spider angiomata in endocarditis. Ala J Med Sci (1971) 0.75
ELECTRICAL AIDS IN PROGNOSIS OF NERVE INJURIES. J Neurol Neurosurg Psychiatry (1947) 0.75
Endocarditis due to group C streptococci. South Med J (1972) 0.75
Pycomycosis. South Med J (1973) 0.75
Cefotaxime aminoglycoside interactions. Chemotherapy (1985) 0.75
Renal function, recovery and rehabilitation after kidney transplantation: an analysis of 30 consecutive patients. Am Surg (1971) 0.75